The convergence of ICT and biomedical sciences presents significant opportunities in developing connected medical devices, enhancing precision medicine, and improving healthcare delivery. This ...

Orchestra BioMed (Nasdaq:OBIO) expects to receive up to $21 million in cash as a result of Haemonetics' recent.

DUBLIN-- (BUSINESS WIRE)--January 13, 2026-- The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030" report has been added to ResearchAndMarkets.com's offering.

Biomedical firm Boston Scientific (BSX) is acquiring Penumbra (PEN), a maker of cardiovascular devices, for $14.5 billion U.S ...

Purdue University researchers have developed a device for more conveniently detecting pathogens in health care settings, on ...

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...

This whitepaper provides MEMS engineers, biomedical device developers, and multiphysics simulation specialists with a practical AI-accelerated workflow for optimizing piezoelectric micromachined ...

Acoustofluidics offers advantages over other microfluidics methods, such as low cost, simplified designs, and remote droplet manipulation. These are especially relevant for applications like ...

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Aiming to facilitate large-scale indigenous manufacturing, this device will secure regulatory approvals, and facilitate the ...

A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...

Analysts have set 12-month price targets for Orchestra BioMed Hldgs, revealing an average target of $14.5, a high estimate of ...